Loading data for ALLR — first visit, this takes a few seconds.

アラート

Allarity Therapeutics Inc... (ALLR)

NasdaqCM: ALLR · リアルタイム株価 · USD

1.41

+0.03 (2.17%)

終値時点： Aug 28, 2026, 8:00 PM

1.40

-0.71%

時間外: 7:16 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

2.17% (1D)

データがありません

買気配	1.03
時価総額	22.43M
売上高（TTM）	345K
純利益（TTM）	-12.33M
	0.51
	-0.79
	n/a
	-1.45
PBR（TTM）	6.35
PSR（TTM）	65.03
決算発表日	n/a

売気配	1.77
出来高	137,996
平均出来高（20日）	116,514
始値	1.38
前日終値	1.38
当日レンジ	1.35 - 1.44
52週レンジ	0.77 - 2.06
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

ALLRについて

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of po...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Dec 21, 2021

従業員数 7

上場取引所 NasdaqCM

ティッカー ALLR

ウェブサイト https://www.allarity.com

企業情報の全文

業績

2025年のAllarity Therapeuticsの売上高は320Kで、前年の0からundefined%の増加でした。利益は-11.23Mで、-54.19%の減少でした。

財務諸表

決算サプライズ

Allarity TherapeuticsはAug 14, 2026に四半期決算を発表しました：

売上高は $25K で、予想を下回りました $0, うち Infinity% の前年比増加にあたります.
EPSは -0.21 で、予想を上回りました 0.04, うち -40.00% の前年比減少.

ニュース

1か月前 · Zacks

Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.

1か月前 · Zacks

Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Amgen (AMGN) have performed compared to their sector so far this year.

2か月前 · Zacks

Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Alterity Therapeutics Limited - Sponsored ADR (ATHE) have performed compared to their sector so far this year.

3か月前 · Zacks

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Here is how Bioventus (BVS) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.

5か月前 · TipRanks

Allarity closes $20M financing for stenoparib advancement

Allarity (ALLR) Therapeutics closed a $20 million non-convertible debt financing with Streeterville Capital. The transaction is structured as a note purchase agreement pursuant to which the Company is...

2ページ中1ページ

Allarity Therapeutics Inc... (ALLR)